Forecast

Financial forecast

Project revenue, EBITDA, net income and free cash flow for the next 5 or 10 years. Growth starts at the same rate the valuation uses and fades to the long-run rate, with margins held at today's level. Bear and bull cases move growth by the company's own revenue volatility. It is a model of what the assumptions imply, not a prediction.

Sanofi (SAN.PA)

Price updated 06 Nov 2026 09:57; Fiscal year 2025; Annual financials downloaded 04 Nov 2026 15:22.

Starts from Fiscal year 2025 financials in EUR and a share price of EUR 82.64. Growth begins at 5.5% a year (the valuation's blended assumption) and fades to 2.9% by year 10. Margins held at EBITDA 26.7%, net 16.7%, free cash flow 15.4% of revenue. Bear and bull move starting growth by 2.0 points and long-run growth by 1 point.

Year 1 uses analyst consensus revenue growth (5.1%); year 2 is halfway back to the model's own path.
EUR 79.34Model fair value (Free-cash-flow DCF); range EUR 57.14 to EUR 117.97
-4%Fair value vs today's price
HighModel confidence
75%Share of the gap to fair value the price closes by year 5

Confidence: Earnings-based DCF agrees; annual data only; profit and cash flow steady for 3 years.

7.5%/yrModel-implied annual total return over 10 years, base case (price plus dividends). Raw model level; the screener shows a calibrated ranking instead
EUR 70.04BRevenue in year 10 (base)
EUR 11.71BNet income in year 10 (base)
EUR 10.81BFree cash flow in year 10 (base)
EUR 5.88Dividend per share in year 10 (base)
EUR 120.18Implied share price in year 10 (base), today EUR 82.64
10.7%Year-10 free cash flow per share vs today's price

Free cash flow over time

EUR 0 EUR 3.12B EUR 6.23B EUR 9.35B EUR 12.47B FY2022 FY2023 FY2024 Fiscal year 2025 +1 +2 +3 +4 +5 +6 +7 +8 +9 +10
Solid: reported Dashed: base projection Shaded: bear to bull range
Free cash flow in year 10 by scenario
CaseStarting growthYear 10Annual growth
Bear 3.1% EUR 9.36B 2.6%
Base 5.1% EUR 10.81B 4.1%
Bull 7.1% EUR 12.47B 5.6%

Base case by year

YearGrowthRevenueEBITDANet incomeFree cash flowEPSFCF / shareDividend / shareBook / shareImplied price
Fiscal year 2025– EUR 46.72BEUR 12.48BEUR 7.81BEUR 7.21B 6.405.913.92n/a82.64
Year 15.1% EUR 49.09BEUR 13.11BEUR 8.21BEUR 7.58B 6.736.214.12n/a86.33
Year 25.1% EUR 51.61BEUR 13.79BEUR 8.63BEUR 7.97B 7.076.534.33n/a90.21
Year 34.9% EUR 54.13BEUR 14.46BEUR 9.05BEUR 8.36B 7.426.854.54n/a94.04
Year 44.6% EUR 56.62BEUR 15.13BEUR 9.47BEUR 8.74B 7.767.164.75n/a97.76
Year 54.3% EUR 59.07BEUR 15.78BEUR 9.88BEUR 9.12B 8.097.474.96n/a101.36
Year 64.0% EUR 61.45BEUR 16.41BEUR 10.28BEUR 9.49B 8.427.775.16n/a105.45
Year 73.8% EUR 63.75BEUR 17.03BEUR 10.66BEUR 9.84B 8.748.065.35n/a109.40
Year 83.5% EUR 65.96BEUR 17.62BEUR 11.03BEUR 10.18B 9.048.345.54n/a113.19
Year 93.2% EUR 68.06BEUR 18.18BEUR 11.38BEUR 10.51B 9.338.615.71n/a116.80
Year 102.9% EUR 70.04BEUR 18.71BEUR 11.71BEUR 10.81B 9.608.865.88n/a120.18

EPS and free cash flow per share assume today's share count. Dividends assume today's payout ratio and book value grows with retained earnings. The implied share price follows the valuation models and is not a price target; override growth settings do not change the model fair value. Margins stay at today's level except where the notes say they drift toward their average, so it does not model margin expansion, buybacks, acquisitions or recessions. It is for information and education only and is not investment advice. See the methodology for how the growth rate is blended.